// App-Quantinova.ai

S4332 2015 AHA : Prolonged QRS Duration Predicts Outcomes in Heart Failure with Preserved Ejection Fraction

Researchers

Presenter

  • Brian L Claggett

Principal Investigators

  • Inder S Anand

  • Eldrin F Lewis

  • Jerome L Fleg

  • Thao Huynh

  • Akshay S Desai

  • Scott D Solomon

  • Eileen -Meara

  • Sonja McKinlay

  • Bertram Pitt

  • Marc A Pfeffer

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • University of Michigan, Ann Arbor, MI

  • New England Research Institutes, Watertown, MA

  • University of Minnesota, Minneapolis, MN

  • CCR, NIH, Bethesda, MD

  • Institut de Rhumatologie, Montreal, QC, Canada

  • Montreal General Hospital, MUHC, Montreal, QC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart failure with preserved ejection fraction

  • Cardiac arrest

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • Spironolactone

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim